Depletion of CD3/CD19 in an autologous stem cell transplant ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
49	Systemic lupus erythematosus	1
51	Scleroderma	1

49. Systemic lupus erythematosus

Clinical trials : 946 / Drugs : 722 - (DrugBank : 186) / Drug target genes : 117 - Drug target pathways : 199

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05029336 (ClinicalTrials.gov)	December 2021	24/8/2021	Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases	Autologous Hematopoietic Stem Cell Transplant for Children and Young Adults With Life Threatening Au ...	Systemic Lupus Erythematosus;Systemic Sclerosis	Biological: Depletion of CD3/CD19 in an autologous stem cell transplant	Stephan Grupp MD PhD	NULL	Recruiting	8 Years	25 Years	All	20	Phase 2	United States

Clinical trials : 523 / Drugs : 608 - (DrugBank : 156) / Drug target genes : 114 - Drug target pathways : 215

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05029336 (ClinicalTrials.gov)	December 2021	24/8/2021	Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases	Autologous Hematopoietic Stem Cell Transplant for Children and Young Adults With Life Threatening Au ...	Systemic Lupus Erythematosus;Systemic Sclerosis	Biological: Depletion of CD3/CD19 in an autologous stem cell transplant	Stephan Grupp MD PhD	NULL	Recruiting	8 Years	25 Years	All	20	Phase 2	United States